Home
About
Overview
Sharing Data
ORCID
Help
History (34)
Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study.
A long noncoding RNA protects the heart from pathological hypertrophy.
Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials.
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial.
Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection.
See All 34 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection.
Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection. Emerg Infect Dis. 2013 Mar; 19(3):416-24.
View in:
PubMed
subject areas
Adolescent
Adult
Antitubercular Agents
Coinfection
Cycloserine
Drug Therapy, Combination
Ethambutol
Ethionamide
Extensively Drug-Resistant Tuberculosis
Female
HIV Infections
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Pyrazinamide
Retrospective Studies
Treatment Outcome
Tuberculosis, Pulmonary
Young Adult
authors with profiles
Charlotte Kvasnovsky